USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma
Cellular Oncology · 2024-12 · 47 (6) · 2217-2231
DOI: 10.1007/s13402-024-01002-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 17.10.2024. Verfasst von Qian Qiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Hypoxia-Inducible Factor 1, alpha Subunit, Ubiquitin Thiolesterase, Glycolysis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Key Project of Wuxi Medical Center, the Key Research and Development Program of Jiangsu Province, the National Natural Science Foundation Project.
Abstract (Originalsprache)
BACKGROUND: Ubiquitination is one of the important modification of proteins which can be reversed by deubiquitinating enzymes (DUBs). Ubiquitin specific protease 28 (USP28) belongs to the deubiquitinase family, which plays a cancer-promoting function in many types of cancers such as pancreatic cancer and breast cancer. So far, the molecular function and significance of USP 28 in cholangiocarcinoma remain unclear. METHODS: In this study, we evaluated the expression of USP28 using tissue microarray (TMA), reverse transcription polymerase chain reaction (qRT-PCR), and online databases. We investigated the effect of USP28 on the progression of CCA through in vitro and in vivo functional experiments. In addition, we explored downstream molecular pathways using Western blotting (WB), immunofluorescence (IF), and mass spectrometry techniques. RESULTS: Here, we found that cholangiocarcinoma tissue had higher USP 28 expression than normal bile duct tissue, and that high USP 28 levels were significantly associated with a malignant phenotype and poorer prognosis in cholangiocarcinoma patients. Both in vitro and in vivo, USP28 could mediate the deubiquitination of PKM2, thereby activating the downstream Hif1-α signaling pathway, promoting glycolysis and energy supply, and finally promoting tumor progression. CONCLUSION: In summary, USP28 activated downstream Hif1-α by reducing the ubiquitination level of PKM2, furthermore, promoting the level of glycolysis in CCA cells for tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu Province, China.
- Hepatobiliary Center, Key Laboratory of Liver Transplantation, The First Affiliated Hospital of Nanjing Medical University, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation,…
- Department of Hepatobiliary Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu Province, China. wumingyuq…
- Department of Hepatobiliary Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu Province, China. drxcli@nj…
Förderung
- the Key Project of Wuxi Medical Center
- the Key Research and Development Program of Jiangsu Province
- the National Natural Science Foundation Project
Zitieren
APA
Qiao, Q., Wang, J., Liu, S., Chang, J., Zhou, T., Li, C., Zhang, Y., Jiang, W., Chen, Y., Xu, X., Wu, M., & Li, X. (2024). USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma. Cellular Oncology, 47(6), 2217-2231. https://doi.org/10.1007/s13402-024-01002-z
Vancouver
Qiao Q, Wang J, Liu S, Chang J, Zhou T, Li C, et al. USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma. Cellular Oncology. 2024;47(6):2217-2231. doi:10.1007/s13402-024-01002-z
BibTeX
@article{Qiao2024,
author = {Qiao, Qian and Wang, Jifei and Liu, Shuochen and Chang, Jiang and Zhou, Tao and Li, Changxian and Zhang, Yaodong and Jiang, Wangjie and Chen, Yananlan and Xu, Xiao and Wu, Mingyu and Li, Xiangcheng},
title = {USP28 promotes tumor progression and glycolysis by stabilizing PKM2/Hif1-α in cholangiocarcinoma},
journal = {Cellular Oncology},
year = {2024},
volume = {47},
number = {6},
pages = {2217--2231},
doi = {10.1007/s13402-024-01002-z}
}
EUVIMED